Illumina is the famous Corporate Investor, which was founded in 1998. The company was established in North America in United States. The main office of represented Corporate Investor is situated in the San Diego.
The fund was created by David R. Walt, John Stuelpnagel, Larry Bock, Satnam Alag.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Illumina, startups are often financed by IP Group Plc, MVI Finance, HBM Healthcare Investments AG. The meaningful sponsors for the fund in investment in the same round are Sutter Hill Ventures, Yaletown Partners, Warburg Pincus. In the next rounds fund is usually obtained by IP Group Plc, Lansdowne Partners, Invesco.
The top amount of exits for fund were in 2015. This Illumina works on 11 percentage points less the average amount of lead investments comparing to the other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year. Considering the real fund results, this Corporate Investor is 7 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2016.
The fund has no exact preference in some founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight GRAIL, Oxford Nanopore Technologies, Human Longevity. Among the most popular fund investment industries, there are Wellness, Genetics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Anjinggao Industry | China, Futian, Guangdong |
| Antheria Holding AG | - |
| Baronsmead Venture Trusts | - |
| Edge Growth | Gauteng, Johannesburg, South Africa |
| FBR CoMotion Venture Capital | Seattle, United States, Washington |
| Ixchel | Chicago, Illinois, United States |
| Jolmo Capital | China, Jiangsu, Nanjing |
| Knife Capital | Gauteng, NA - South Africa, South Africa |
| Krummacher Group | Switzerland, Zürich, Zurich |
| MedPeer | Japan, Tokyo |
| New The Future | Beijing, Beijing, China |
| Sparta | Stockholm, Stockholm County, Sweden |
| Suzhou Jusong | China, Jiangsu, Suzhou |
| Thrive Partners | - |
| TLG Capital | England, London, United Kingdom |
| United States African Development Foundation | District of Columbia, United States, Washington |
| Vito Ventures | Bayern, Germany, Munich |
| Xincheng Investment | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Mantra Bio | $9M | 04 Jan 2023 | San Francisco, California, United States | ||
Neurolytic Healthcare | 27 Jul 2022 | Oxford, Oxfordshire, United Kingdom | |||
ConcR | $684K | 01 Apr 2021 | London, England, United Kingdom | ||
Helix | $200M | 01 Mar 2018 | California, United States | ||
Prospect Bio | $2M | 15 Nov 2016 | California, United States | ||
Vitagene | $2M | 17 Feb 2016 | San Francisco, California, United States | ||
Grail | $100M | 12 Jan 2016 | California, United States | ||
Helix | $100M | 15 Aug 2015 | California, United States | ||
Twist Bioscience | $37M | 09 Jun 2015 | San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Mantra Bio | $9M | 04 Jan 2023 | San Francisco, California, United States | ||
Neurolytic Healthcare | 27 Jul 2022 | Oxford, Oxfordshire, United Kingdom | |||
ConcR | $684K | 01 Apr 2021 | London, England, United Kingdom | ||
Helix | $200M | 01 Mar 2018 | California, United States | ||
Prospect Bio | $2M | 15 Nov 2016 | California, United States | ||
Vitagene | $2M | 17 Feb 2016 | San Francisco, California, United States | ||
Grail | $100M | 12 Jan 2016 | California, United States | ||
Helix | $100M | 15 Aug 2015 | California, United States | ||
Twist Bioscience | $37M | 09 Jun 2015 | San Francisco, California, United States |
